Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00376883
Status:
COMPLETED
Last Update Posted:
2007-01-04
First Post:
2006-09-14
Brief Title:
Pamidronate Prophylaxis in Multiple Myeloma 30 mgMonth Versus 90 mgMonth
Sponsor:
Nordic Myeloma Study Group
Organization:
Nordic Myeloma Study Group
Organization Data
Organization:
Nordic Myeloma Study Group
Class:
OTHER
Study ID:
NMSG 0800
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nordic Myeloma Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nordic Cancer Union | OTHER |